<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Daily Stocks News &#187; GG</title>
	<atom:link href="http://news.dailystocks.com/tag/gg/feed/" rel="self" type="application/rss+xml" />
	<link>http://news.dailystocks.com</link>
	<description>Stocks with Insider Buying, Stock Search Engine, Glossary, Education, Reviews</description>
	<lastBuildDate>Mon, 21 Jan 2019 17:42:26 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Major Movers on April 15; THRX, ACOR, LIFE, TMO, NGD, ABX, GG, WLT, S</title>
		<link>http://news.dailystocks.com/2776/major-movers-on-april-15-thrx-acor-life-tmo-ngd-abx-gg-wlt-s/</link>
		<comments>http://news.dailystocks.com/2776/major-movers-on-april-15-thrx-acor-life-tmo-ngd-abx-gg-wlt-s/#comments</comments>
		<pubDate>Mon, 15 Apr 2013 19:53:48 +0000</pubDate>
		<dc:creator>Warren Paige</dc:creator>
				<category><![CDATA[Large Cap Growth Stocks]]></category>
		<category><![CDATA[ABX]]></category>
		<category><![CDATA[ACOR]]></category>
		<category><![CDATA[GG]]></category>
		<category><![CDATA[LIFE]]></category>
		<category><![CDATA[NGD]]></category>
		<category><![CDATA[S]]></category>
		<category><![CDATA[THRX]]></category>
		<category><![CDATA[TMO]]></category>
		<category><![CDATA[WLT]]></category>

		<guid isPermaLink="false">http://news.dailystocks.com/?p=2776</guid>
		<description><![CDATA[<p>Shares of Theravance Inc. (NASDAQ: THRX) rallied on Monday after a report from the U.S. drug regulators showed that the once-a-day lung disease treatment Breo Ellipta, which the company is developing in conjunction with the GlaxoSmithKline Plc, might get an approval.</p> <p></p> <p>The FDA’s pulmonary allergy advisory committee will review the inhaler Breo Ellipta on [...]]]></description>
		<wfw:commentRss>http://news.dailystocks.com/2776/major-movers-on-april-15-thrx-acor-life-tmo-ngd-abx-gg-wlt-s/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
